This page lists the SEC filings reported by Frazier Healthcare V, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2020-11-18 | Frazier Healthcare V, LP | ANAPTYSBIO, INC | 899,700 | 3.3% | EDGAR |
| SC 13D/A | 2019-02-14 | Frazier Healthcare V, LP | ANAPTYSBIO INC | 2,316,447 | 8.7% | EDGAR |
| SC 13D/A | 2018-05-15 | Frazier Healthcare V, LP | ANAPTYSBIO INC | 2,316,447 | 9.7% | EDGAR |
| SC 13D/A | 2018-02-26 | Frazier Healthcare V, LP | ANAPTYSBIO INC | 3,688,447 | 15.7% | EDGAR |
| SC 13G/A | 2017-02-14 | Frazier Healthcare V, LP | GLAUKOS Corp | - | - | EDGAR |
| SC 13D | 2017-02-10 | Frazier Healthcare V, LP | ANAPTYSBIO INC | 3,688,447 | 18.5% | EDGAR |
| SC 13D/A | 2016-11-03 | Frazier Healthcare V, LP | Tobira Therapeutics, Inc. | - | - | EDGAR |
| SC 13G/A | 2016-03-08 | Frazier Healthcare V, LP | Zeltiq Aesthetics Inc | - | - | EDGAR |
| SC 13G | 2016-02-16 | Frazier Healthcare V, LP | GLAUKOS Corp | 2,603,362 | 8.1% | EDGAR |
| SC 13D | 2015-05-18 | Frazier Healthcare V, LP | Tobira Therapeutics, Inc. | 2,668,570 | 15.3% | EDGAR |
| SC 13G | 2012-02-07 | Frazier Healthcare V, LP | Zeltiq Aesthetics Inc | 7,427,244 | 21.9% | EDGAR |
| SC 13D/A | 2009-03-02 | Frazier Healthcare V, LP | LA JOLLA PHARMACEUTICAL CO | 0 | 0.0% | EDGAR |
| SC 13G/A | 2009-02-20 | Frazier Healthcare V, LP | CADENCE PHARMACEUTICALS INC | 4,894,035 | 9.7% | EDGAR |
| SC 13G/A | 2009-02-13 | Frazier Healthcare V, LP | CADENCE PHARMACEUTICALS INC | 4,372,659 | 11.4% | EDGAR |
| SC 13D/A | 2008-11-14 | Frazier Healthcare V, LP | ENDOCARE INC | 1,721,915 | 14.6% | EDGAR |
| SC 13D | 2008-01-04 | Frazier Healthcare V, LP | ENDOCARE INC | 1,697,563 | 14.6% | EDGAR |
| SC 13G/A | 2007-12-10 | Frazier Healthcare V, LP | ENDOCARE INC | 1,580,896 | - | EDGAR |
| SC 13G | 2007-06-04 | Frazier Healthcare V, LP | ENDOCARE INC | 3,255,814 | - | EDGAR |
| SC 13G | 2007-02-14 | Frazier Healthcare V, LP | CADENCE PHARMACEUTICALS INC | 25,000,000 | - | EDGAR |
| SC 13D | 2005-12-27 | Frazier Healthcare V, LP | LA JOLLA PHARMACEUTICAL CO | 5,000,000 | 13.6% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.